Stockreport

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and [Read more]